参考文献/References:
[1] 古 川,徐小元,熊 辉.肝硬化食管胃静脉曲张的一级预防和二级预防[J].实用肝脏病杂志,2016,19(5):513-515.
[2] 章 伶,荀运浩,过建春.应用临床路径管理特利加压素治疗肝硬化并发食管胃底静脉曲张破裂出血不良反应的效果[J].中华全科医学,2018,16(7):1220-1223.
[3] 何秋仙,王秋莲,王芳婷.肝硬化并发上消化道出血内镜下硬化剂治疗术后早期进食探讨[J].陕西医学杂志,2015,44(9):1269.
[4] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会消化内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].中华内科杂志,2016,55(1):57-72.
[5] 陈巧玲,韩一梅,朱云清,等.乙氧硬化醇和聚桂醇治疗食管静脉曲张破裂出血疗效及并发症比较[J].陕西医学杂志,2014,43(3):349-350.
[6] 中华医学会外科分会血管外科学组.慢性下肢静脉疾病诊断与治疗中国专家共识[J].中华普通外科杂志,2014,29(4):246-252.
[7] 田永飞,彭金军.泡沫硬化联合化瘀散结方外敷治疗下肢静脉曲张临床研究[J].陕西中医,2018,39(2):223-225.
[8] 李 龙.《慢性静脉疾病硬化疗法欧洲指南》解读[J].介入放射学杂志,2016,25(9):743-749.
[9] 李 凯,董立新,刘少华.泡沫硬化剂治疗脉管性疾病新进展[J].口腔医学,2013,33(2):130-132.
[10] Tessari L,Cavezzi A,Frullini A.Preliminary experience with a new sclerosing foam in the treatment of varicose veins[J].Dermatologic Surgery,2001,27(1):58-60.
[11] 邱 天,崔 明,严 枫,等.泡沫硬化疗法—我们的新选择[J].西南国防医药,2012,22(12):1426-1428.
[12] Moser K,Mosch C,Walgenbach M.et al.Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease:a randomised,controlled,single-blind,multicentre trial[J].Int J Colorectal Dis,2013,28(10):1439-1447.
[13] Farooq FT,Wong RCK.Injection sclerotherapy for the management of esophageal and gastric varices[J].Techniques in Gastrointestinal Endoscopy,2005,7(1):8-17.
[14] 郭 皓,李 艺,张 刚.静脉畸形硬化疗法的新进展[J].中国实用医药,2019,14(1):192-194.
[15] 张春荣,郑如恒,葛 棣.SD大鼠气管黏膜下注射硬化剂后VEGF表达及成纤维细胞的增生[J].中国临床医学,2007,14(3):327-328.
[16] Breu FX,Guggenbichler S,Wollmann JC.2nd European consensus meeting on foam sclerotherapy 2006,Tegernsee,Germanyl[J].Vasa Dis,2008,37(71):1-29.
[17] Smith CP.Foam and liquid sclerotherapy for varicose veins[J].Phlebology,2009,24(1):62-72.
[18] Ukritmanoroat T.Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy:a controlled clinical trial[J].Journal of the Medical Association of Thailand,2011,94(2):35-40.
[19] 杨培生,李宏为.大鼠股静脉注射三种硬化剂后的病理变化[J].蚌埠医学院学报,1999,24(6):385-387.